Results 241 to 250 of about 1,277,493 (295)
Exploring EBNA3C Genetic Variability and Recombination in Epstein-Barr Virus-Associated Cancers. [PDF]
Int J Mol SciBarra A +3 more
europepmc +1 more source
CRISPR-Engineered CAR-T Cell Therapy for Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: A Review of Emerging Therapeutic Prospects. [PDF]
Rev Med VirolAllehyani N +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Epstein-Barr virus and carcinomas
International Journal of Clinical & Laboratory Research, 1993The Epstein-Barr virus, a human B lymphotropic herpes virus, is strongly associated with undifferentiated nasopharyngeal carcinoma, which is endemic in Southern China and North Africa. More recently, an association of the virus with certain other epithelial malignancies has been described, some of which are more common in Western countries.
G, Niedobitek, H, Herbst, L S, Young
openaire +2 more sources
Epstein-Barr virus dacryoadenitis
American Journal of Ophthalmology, 2000To describe the clinical features of lacrimal gland inflammation associated with Epstein-Barr virus infection.The clinical records, laboratory data, and radiographs of patients who had inflammation of one or both lacrimal glands that had begun less than 4 weeks previously were reviewed.Sixteen patients with dacryoadenitis were encountered between 1980 ...
M N, Rhem, K R, Wilhelmus, D B, Jones
openaire +2 more sources
Epstein-Barr Virus and Depression
Archives of General Psychiatry, 1986To the Editor.— The clinical syndrome infectious mononucleosis, known to be caused by Epstein-Barr virus (EBV) infection, classically is described as a generalized malaise with fatigue, pharyngitis, and enlarged lymph nodes; however, depression also commonly accompanies these symptoms.
L E, DeLisi +4 more
openaire +2 more sources
Novel Therapeutics for Epstein–Barr Virus [PDF]
Molecules, 2019 Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult population. Primary EBV infection usually occurs during childhood and is generally asymptomatic, though the virus can cause infectious mononucleosis in 35–50% of the cases when infection occurs later in life.
Robert Snoeck +2 more
exaly +4 more sources
European Journal of Internal Medicine, 2011
Epstein-Barr Virus (EBV) infection has the potential to establish life-long, benign infections in their hosts. Although biochemical evidence of hepatocellular damage is common, jaundice is uncommon and complete recovery is the rule. The present study describes clinical characteristics and changes of liver function tests during the course of infectious ...
George Samonis, Mairi Koulentaki
exaly +3 more sources
Epstein-Barr Virus (EBV) infection has the potential to establish life-long, benign infections in their hosts. Although biochemical evidence of hepatocellular damage is common, jaundice is uncommon and complete recovery is the rule. The present study describes clinical characteristics and changes of liver function tests during the course of infectious ...
George Samonis, Mairi Koulentaki
exaly +3 more sources
Histopathology, 1996
The Epstein‐Barr virus (EBV) is the best characterized human virus known to infect most people all over the world. In most cases, primary infection with EBV is asymptomatic and the virus persists life‐long without causing any disease. The availability of sensitive detection methods, however, has led to the identification of a wide array of EBV ...
I, Anagnostopoulos, M, Hummel
openaire +2 more sources
The Epstein‐Barr virus (EBV) is the best characterized human virus known to infect most people all over the world. In most cases, primary infection with EBV is asymptomatic and the virus persists life‐long without causing any disease. The availability of sensitive detection methods, however, has led to the identification of a wide array of EBV ...
I, Anagnostopoulos, M, Hummel
openaire +2 more sources
Annual Review of Pathology: Mechanisms of Disease, 2019
Epstein–Barr virus (EBV) contributes to about 1.5% of all cases of human cancer worldwide, and viral genes are expressed in the malignant cells. EBV also very efficiently causes the proliferation of infected human B lymphocytes. The functions of the viral proteins and small RNAs that may contribute to EBV-associated cancers are becoming increasingly ...
openaire +2 more sources
Epstein–Barr virus (EBV) contributes to about 1.5% of all cases of human cancer worldwide, and viral genes are expressed in the malignant cells. EBV also very efficiently causes the proliferation of infected human B lymphocytes. The functions of the viral proteins and small RNAs that may contribute to EBV-associated cancers are becoming increasingly ...
openaire +2 more sources
Vaccine, 1992
Epstein-Barr virus (EBV) is a human viral pathogen of considerable importance. More than 95% of the human population world-wide becomes infected with the virus during childhood, although in the West infection may be delayed until adolescence. The infection only has an undesirable significant clinical outcome in a tiny minority of cases, but because the
openaire +2 more sources
Epstein-Barr virus (EBV) is a human viral pathogen of considerable importance. More than 95% of the human population world-wide becomes infected with the virus during childhood, although in the West infection may be delayed until adolescence. The infection only has an undesirable significant clinical outcome in a tiny minority of cases, but because the
openaire +2 more sources